The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I think this means, they are looking for up front payments from 3rd parties in exchange for marketing and percentage of sales
Confidential discussions commenced with third parties regarding monetizing OBD's two most advanced pipeline assets: EpiSwitch® NST (No Stool Test) for colorectal/bowel cancer and EpiSwitch® SCB (Specific for Canine Blood) blood test for detection of multiple types of canine cancer
Yes Dug, certainly a lot of positive publicity confirming results will be out on the 17th! Makes you think they want as much exposure as possible, not the actions of a company trying to kick the can down the road by quietly reporting late.
We also have a Covid Severity blood Test (EpiSwitch CST) available for purchase, sales would of picked up for sure, maybe not substantial, but every little helps.
https://store.oxfordbiodynamics.com/en-gb/products/episwitch-cst
OBD getting excited about presenting on the 17th, they must be happy things are going to plan or even better!
Just two weeks until #PMWC24! If you’re attending, be sure to connect with the #OBD team at booth D1048. We’re excited to discuss the latest advancements in #PrecisionMedicine, including our 94% accurate EpiSwitch® Prostate Screening (PSE) test
@94percent_com
.